Description

Bisoprolol Fumarate USP/EP

Bisoprolol Fumarate USP/EP is a high-purity cardioselective beta-adrenergic receptor blocking agent used in pharmaceutical formulations for the management of cardiovascular conditions. Compliant with United States Pharmacopeia (USP) and European Pharmacopoeia (EP) standards, it is widely utilized in oral dosage forms for treatment of hypertension, chronic heart failure, and related cardiovascular disorders.
Bisoprolol Fumarate appears as a white to off-white crystalline powder that is freely soluble in water and soluble in alcohol. It is the fumarate salt of Bisoprolol, a selective Beta1-Adrenergic receptor antagonist that primarily affects cardiac tissue while minimizing activity at Beta2 receptors.
In pharmaceutical and research applications, Bisoprolol Fumarate USP/EP is used in:
• Oral tablet formulations for hypertension management
• Pharmaceutical products for chronic heart failure treatment
• Cardiovascular therapy research and development
• Pharmacological studies involving beta-adrenergic receptor modulation
• Bioavailability and pharmacokinetic studies
• Development of combination cardiovascular therapies
Bisoprolol Fumarate USP/EP functions by selectively blocking Beta1-Adrenergic receptors in cardiac tissue, resulting in reduced heart rate, decreased myocardial contractility, and lowered blood pressure. This mechanism supports improved cardiovascular function and reduced cardiac workload.
CarboMer supplies Bisoprolol Fumarate USP/EP with defined assay, impurity profile, and physicochemical properties suitable for regulated pharmaceutical manufacturing and formulation development.
The material meets USP and EP monograph specifications and is appropriate for controlled pharmaceutical production environments.
The material is packaged in sealed, moisture-resistant, tamper-evident containers and protected from excessive light to preserve stability and handling quality. Available in laboratory, pilot, and commercial-scale quantities. Documentation includes Certificate Of Analysis (CoA), Safety Data Sheet (SDS), and full traceability.
Each batch is tested for identity, assay, impurity profile, water content, and related substances where applicable. Technical support is available to assist with formulation development, stability considerations, and regulatory alignment.
As with all CarboMer supplied active pharmaceutical ingredients, Bisoprolol Fumarate USP/EP is supported by dependable global supply, rigorous quality systems, and expert technical guidance to ensure consistent and reliable performance across pharmaceutical applications.